BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy.Tools Födermayr, M, Sebesta, M, Rudas, M, Berghoff, AS, Promberger, R, Preusser, M, Dubsky, P, Fitzal, F, Gnant, M, Steger, GG, Weltermann, A, Zielinski, CC, Zach, O and Bartsch, R (2014) BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy. Cancer Chemother Pharmacol.. Full text not available from this repository.
Actions (login required) |
||||||||||||||
![]() |
|
![]() |